This is the Biologics License Application (BLA) number for Actemra (tocilizumab) . Specifically, it covers the subcutaneous injection formulation used to treat conditions like moderate to severe Rheumatoid Arthritis .
Filing #125472 relates to a USPS response to a Chairman's Information Request under seal, filed in June 2023. Filing 125472 - Postal Regulatory Commission - ArkCase 125472
You can find the official approval letters and clinical review summaries on the FDA's Drugs@FDA database. This is the Biologics License Application (BLA) number
A "useful post" for developers titled Form Mail Script , where a user discusses making an email form functional within an HTML template. 125472